62 related articles for article (PubMed ID: 20477494)
1. Guanylyl cyclase C as a biomarker for targeted imaging and therapy of metastatic colorectal cancer.
Chang C; Marszlowicz G; Waldman Z; Li P; Snook AE; Lin JE; Schulz S; Waldman SA
Biomark Med; 2009 Feb; 3(1):33-45. PubMed ID: 20477494
[TBL] [Abstract][Full Text] [Related]
2. Heterogeneity of guanylyl cyclase C expressed by human colorectal cancer cell lines in vitro.
Waldman SA; Barber M; Pearlman J; Park J; George R; Parkinson SJ
Cancer Epidemiol Biomarkers Prev; 1998 Jun; 7(6):505-14. PubMed ID: 9641495
[TBL] [Abstract][Full Text] [Related]
3. Guanylyl cyclase C: a molecular marker for staging and postoperative surveillance of patients with colorectal cancer.
Frick GS; Pitari GM; Weinberg DS; Hyslop T; Schulz S; Waldman SA
Expert Rev Mol Diagn; 2005 Sep; 5(5):701-13. PubMed ID: 16149873
[TBL] [Abstract][Full Text] [Related]
4. Guanylyl cyclase C suppresses intestinal tumorigenesis by restricting proliferation and maintaining genomic integrity.
Li P; Schulz S; Bombonati A; Palazzo JP; Hyslop TM; Xu Y; Baran AA; Siracusa LD; Pitari GM; Waldman SA
Gastroenterology; 2007 Aug; 133(2):599-607. PubMed ID: 17681179
[TBL] [Abstract][Full Text] [Related]
5. Guanylyl cyclase C as a reliable immunohistochemical marker and its ligand Escherichia coli heat-stable enterotoxin as a potential protein-delivering vehicle for colorectal cancer cells.
Buc E; Vartanian MD; Darcha C; Déchelotte P; Pezet D
Eur J Cancer; 2005 Jul; 41(11):1618-27. PubMed ID: 15919201
[TBL] [Abstract][Full Text] [Related]
6. Cholecystokinin-B (CCK-B)/gastrin receptor targeting peptides for staging and therapy of medullary thyroid cancer and other CCK-B receptor expressing malignancies.
Béhé M; Behr TM
Biopolymers; 2002; 66(6):399-418. PubMed ID: 12658727
[TBL] [Abstract][Full Text] [Related]
7. A validated quantitative assay to detect occult micrometastases by reverse transcriptase-polymerase chain reaction of guanylyl cyclase C in patients with colorectal cancer.
Schulz S; Hyslop T; Haaf J; Bonaccorso C; Nielsen K; Witek ME; Birbe R; Palazzo J; Weinberg D; Waldman SA
Clin Cancer Res; 2006 Aug; 12(15):4545-52. PubMed ID: 16899600
[TBL] [Abstract][Full Text] [Related]
8. Topological mimicry and epitope duplication in the guanylyl cyclase C receptor.
Nandi A; Suguna K; Surolia A; Visweswariah SS
Protein Sci; 1998 Oct; 7(10):2175-83. PubMed ID: 9792105
[TBL] [Abstract][Full Text] [Related]
9. Guanylyl cyclase C is a selective marker for metastatic colorectal tumors in human extraintestinal tissues.
Carrithers SL; Barber MT; Biswas S; Parkinson SJ; Park PK; Goldstein SD; Waldman SA
Proc Natl Acad Sci U S A; 1996 Dec; 93(25):14827-32. PubMed ID: 8962140
[TBL] [Abstract][Full Text] [Related]
10. Applications of nanoparticles to diagnostics and therapeutics in colorectal cancer.
Fortina P; Kricka LJ; Graves DJ; Park J; Hyslop T; Tam F; Halas N; Surrey S; Waldman SA
Trends Biotechnol; 2007 Apr; 25(4):145-52. PubMed ID: 17316852
[TBL] [Abstract][Full Text] [Related]
11. Proliferative signaling by store-operated calcium channels opposes colon cancer cell cytostasis induced by bacterial enterotoxins.
Kazerounian S; Pitari GM; Shah FJ; Frick GS; Madesh M; Ruiz-Stewart I; Schulz S; Hajnóczky G; Waldman SA
J Pharmacol Exp Ther; 2005 Sep; 314(3):1013-22. PubMed ID: 15937149
[TBL] [Abstract][Full Text] [Related]
12. Cytoplasmic domains mediate the ligand-induced affinity shift of guanylyl cyclase C.
Deshmane SP; Parkinson SJ; Crupper SS; Robertson DC; Schulz S; Waldman SA
Biochemistry; 1997 Oct; 36(42):12921-9. PubMed ID: 9335551
[TBL] [Abstract][Full Text] [Related]
13. Consistent expression of guanylyl cyclase-C in primary and metastatic gastrointestinal cancers.
Danaee H; Kalebic T; Wyant T; Fassan M; Mescoli C; Gao F; Trepicchio WL; Rugge M
PLoS One; 2017; 12(12):e0189953. PubMed ID: 29261789
[TBL] [Abstract][Full Text] [Related]
14. Analytical performance of a qRT-PCR assay to detect guanylyl cyclase C in FFPE lymph nodes of patients with colon cancer.
Beaulieu M; Desaulniers M; Bertrand N; Deschesnes RG; Beaudry G; Garon G; Haince JF; Houde M; Holzer TJ
Diagn Mol Pathol; 2010 Mar; 19(1):20-7. PubMed ID: 20186008
[TBL] [Abstract][Full Text] [Related]
15. Guanylyl cyclase C is a marker of intestinal metaplasia, dysplasia, and adenocarcinoma of the gastrointestinal tract.
Birbe R; Palazzo JP; Walters R; Weinberg D; Schulz S; Waldman SA
Hum Pathol; 2005 Feb; 36(2):170-9. PubMed ID: 15754294
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo evaluation of 111In-labeled E. coli heat-stable enterotoxin analogs for specific targeting of human breast cancers.
Giblin MF; Gali H; Sieckman GL; Owen NK; Hoffman TJ; Volkert WA; Forte LR
Breast Cancer Res Treat; 2006 Jul; 98(1):7-15. PubMed ID: 16724166
[TBL] [Abstract][Full Text] [Related]
17. Opportunities for near-infrared thermal ablation of colorectal metastases by guanylyl cyclase C-targeted gold nanoshells.
Waldman SA; Fortina P; Surrey S; Hyslop T; Kricka LJ; Graves DJ
Future Oncol; 2006 Dec; 2(6):705-16. PubMed ID: 17155897
[TBL] [Abstract][Full Text] [Related]
18. Epidermal growth factor receptor (EGFR) status in primary colorectal tumors does not correlate with EGFR expression in related metastatic sites: implications for treatment with EGFR-targeted monoclonal antibodies.
Scartozzi M; Bearzi I; Berardi R; Mandolesi A; Fabris G; Cascinu S
J Clin Oncol; 2004 Dec; 22(23):4772-8. PubMed ID: 15570078
[TBL] [Abstract][Full Text] [Related]
19. A splice variant of the transcript for guanylyl cyclase C is expressed in human colon and colorectal cancer cells.
Pearlman JM; Prawer SP; Barber MT; Parkinson SJ; Schulz S; Park J; Zook M; Waldman SA
Dig Dis Sci; 2000 Feb; 45(2):298-305. PubMed ID: 10711442
[TBL] [Abstract][Full Text] [Related]
20. An intracellular adenine nucleotide binding site inhibits guanyly cyclase C by a guanine nucleotide-dependent mechanism.
Parkinson SJ; Waldman SA
Biochemistry; 1996 Mar; 35(10):3213-21. PubMed ID: 8605156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
